Linda S. Ahn

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

Mrinal M. Gounder, Robert A. Lefkowitz, Mary Louise Keohan et al. · Clinical Cancer Research · 2011 · 252 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)

Veridiana Pires de Camargo, Mary Louise Keohan, David R. D’Adamo et al. · Cancer · 2010 · 214 citations · Full text

Medicine, Oncology, Chemotherapy +7

Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung Cancers

Helena A. Yu, Adam J. Schoenfeld, Alex Makhnin et al. · JAMA Oncology · 2020 · 131 citations · Full text

Medicine, Oncology, Pharmacology +12

Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas

Juliana Schilsky, Ai Ni, Linda S. Ahn et al. · Lung Cancer · 2017 · 68 citations

Medicine, Cancer Biology, Oncology +16

Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases

Kathryn C. Arbour, Mark G. Kris, Gregory J. Riely et al. · Cancer · 2017 · 37 citations · Full text

Medicine, Oncology, Pharmacology +14